Notice Pursuant to The National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 79219-79221 [2020-26978]
Download as PDF
Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices
Specifically, ANSYS, Inc., Canonsburg,
PA, has been added as a party to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and EVESE
intends to file additional written
notifications disclosing all changes in
membership.
On September 24, 2020, EVESE filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on October 15, 2020 (85
FR 65423).
The last notification was filed with
the Department on October 20, 2020. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on November 19, 2020 (85 FR
73750).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2020–26975 Filed 12–8–20; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
jbell on DSKJLSW7X2PROD with NOTICES
Notice Pursuant to The National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on
November 18, 2020, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Medical Technology Enterprise
Consortium (‘‘MTEC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Abram Scientific, Inc.,
Menlo Park, CA; Accenture Federal
Services, Arlington, VA; Ace
Laboratories Inc., Yarrow Point, WA;
Aceso Plasma, Virginia Beach, VA; ACF
Technologies, Inc, Asheville, NC;
Action Medical Technologies LLC,
Conshohocken, PA; Acuity Systems,
LLC, Herndon, VA; Aerpio
Pharmaceuticals, Cincinnati, OH;
AirStrip Technologies, San Antonio,
TX; Airway Medical Innovations Pty
Ltd, Brisbane Queensland, AUS;
Aktivax, Inc., Broomfield, CO; Allvivo
VerDate Sep<11>2014
16:16 Dec 08, 2020
Jkt 253001
Vascular, Inc., Lake Forest, CA;
Altimmune, Inc., Gaithersburg, MD;
Amydis, Inc., San Diego, CA; Aptahem
AB, Malmo, SWE; Aptive Resources,
LLC, Alexandria, VA; ARD Global LLC,
McLean, VA; Articulate Labs, Dallas,
TX; Ashvattha Therapeutics, Inc,
Redwood City, CA; Astrocyte
Pharmaceuticals Inc., Cambridge, MA;
Asymmetric Technologies, LLC,
Columbus, OH; Athena GTX, Johnston,
IA; Atomo, Inc, West Lake Hills, TX;
Augusta University Resarch lnstitute,
Inc., Augusta, GA; Augustine
Consulting, Inc. (ACI), Monterrey, CA;
Auxocell Laboratories, Inc, Cambridge,
MA; Avera Health, Sioux Falls, SD;
Bambu Vault, LLC, Lowell, MA; Berry
Consultants, LLC, Austin, TX; Beyond
Barriers Therapeutics, Inc., Glencoe, IL;
Bioflight, LLC, Akron, OH;
BioGenerator, Saint Louis, MO; Biotags
LLC, Key Biscayne, FL; Blue Cirrus
Consulting LLC, Greenville, SC; Board
of Trustees of the University of Illinois,
Champaign, IL; Brainbox Solutions Inc.,
Richmond, VA; CAPRICOR
THERAPEUTICS, INC., Beverly, CA;
Carahsoft Technology Corporation,
Reston, VA; Centivax, Inc., South San
Francisco; Ceras Health Inc., New York,
NY; Channel Clinical Solutions, LLC,
Raleigh, NC; Chenega Reliable Services,
LLC, San Antonio, TX; Cherish Health,
Inc., Cambridge, MA; Clarkson
University, Potsdam, NY; Coalition for
National Trauma Research, San
Antonio, TX; Computer Technology
Associates, Inc., Ridgecrest, CA; Conflict
Kinetics Corporation, Sterling, VA; Core
Mobile Networks Inc.; DBA Core Mobile
Inc., Campbell, CA; Crimson
Government LLC, Carlisle, OH; Curza
Global, LLC, Salt Lake City, UT; Data
Intelligence Technologies, Inc.,
Arlington, VA; DEFTEC Corporation,
Huntsville, AL; Digital For Mental
Health (MYNDBLUE), Paris, FRA;
Diomics Corporation, Murrietta, CA;
DocBox Inc., Waltham, MA; EchoNous
Inc., Redmond, WA; ECI Defense Group,
Lyles, TN; Empatica, Inc., Boston, MA;
Endomedix Inc., Montclair, NJ;
Etiometry Inc., Boston, MA; Eumentis
Therapeutics Inc, Newton, MA; Exciton
Technologies Inc., Edmonton, Alberta,
CAN; Expesicor Inc., Missoula, MT;
FesariusTherapeutics Inc., Brooklyn,
NY; FHI Clinical Inc., Durham, NC,
Fitbit, Inc., San Franciso, CA; Flashback
Technologies, Inc., Louisville, CO;
FloTBI Inc., Cleveland, OH; FUJIFILM
Pharmaceuticals USA, Inc., Valhalla,
NY; GelMEDIX Inc., Newton, MA;
GeneCapture, Inc., Huntsville, AL;
General Biologics Inc., Cambridge, MA;
Get Help Now LLC, Fort Myers, FL;
GreyScan Inc., Melbourne, FL; Heat
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
79219
Biologics, Morrisville, NC; Hememics
Biotechnologies Inc, Gaithersburg, MD;
Hough Ear Institute, Oklahoma City,
OK; Humanetics Corporation, Edina,
MN; Hybrid Plastics Inc., Hattiesburg,
MS; Iacta Pharmaceuticals Inc, Irvine,
CA; Ichor Sciences, LLC, Nashville, TN;
ImmunoVation, LLC, Pasadena, CA;
INCELL Corporation LLC, San Antonio,
TX; Infectious Disease Research
Institute, Seattle, WA; Inflammatory
Response Research Inc., Santa Barbara,
CA; Informa Business Intelligence Inc.,
New York, NY; Inhalon Biopharma, Inc.,
Durham, NC; Innovenn, Inc., Madison,
WI; Innsightful, Inc., Sunnyvale, CA;
Integrated Computer Solutions, Inc.,
Waltham, MA; InTouch Technologies,
D/B/A Inc. InTouch Health, Goleta, CA;
J.R. Reingold & Associates, Inc,
Alexandria, VA; JTEK Data Solutions,
LLC, Bethesda, MD; KMASS
SOLUTIONS, El Paso, TX; Knowmadics,
Inc., Herndon, VA; Level Ex, Inc.,
Chicago, IL; LifeQ, Inc, Alphaertta, GA;
LMI Consulting, LLC, Tysons, VA;
LOGGEREX INC., Deland, FL; Lumen
Bioscience, Inc., Seattle, WA; Luna
Innovations Incorporated, Roanoke, VA;
MadApparel Ind. DBA Athos, Redwood
City, CA; ManTech Advanced Systems
International, Inc., Herndon, VA; Mantel
Technologies Inc., Fort Collins, CO;
Masimo Corporation, Irvine, CA;
Materials Modification Inc., Fairfax, VA;
Medcura, Inc., Riverdale, MD; Media
Riders Inc., Pearland, TX; Medical
Center of the Americas Foundation, El
Paso, TX; Medicortex Finland Oy,
Turku, FIN; Medtrade Products Limited,
Crew, Cheshire, GBR; MEMBIO INC.,
Kitchener, CAN; Mespere LifeSciences
Inc., Waterloo, Ontario, CAN;
MicroHealth, LLC, Vienna, VA;
Microsoft, Redmon, VA; Millennium
Enterprise Corporation, Fairfax, VA;
Mineurva LLC, Albuquerque, NM;
Moberg Analytics Inc., Ambler, PA;
Moleculin Biotech, Inc., Houston, TX;
Nanowear Inc., New York, NY;
Neuronasal Inc, Wexford, PA;
Neuronoff, Inc., Valencia, CA; New
Horizons Diagnostics Corporation,
Baltimore, MD; New Jersey Institute of
Technology, Newark, NJ; NoMo
Diagnostics, Chicago, IL; Non-Invasive
Medical Systems LLC, Stamford, CT;
North Carolina State University,
Raleigh, NC; Northwestern University,
Evanson, IL; Nostromo, LLC,
Kennebunk, ME; Nuada Orthopedics,
Inc., Sherborn, MA; Nyrada Inc.,
Gordon, AUS; Obatala Sciences, Inc.,
New Orleans, LA; Oculogica, Inc., New
York, NY; Odin Technologies, Chicago,
IL; OLGS Inc., Imperial, PA; Oregon
Health & Science University, Portland,
OR; Otolith Labs, Washington, DC;
E:\FR\FM\09DEN1.SGM
09DEN1
jbell on DSKJLSW7X2PROD with NOTICES
79220
Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices
Panakeia LLC, Newport News, VA;
Parnell Pharmaceuticals Inc., San
Rafael, CA; Patchd, Inc., San Francisco,
CA; Perspecta Enterprise Solutions LLC,
Herndon, VA; Pinteon Therapeutics,
Newton Center, MA; Posit Science
Corporation, San Francisco, CA; PPD
Development LP, Wilmington, NC;
Predictions Systems Inc., Spring Lake,
NJ; Promaxo, Oakland, CA; QUASAR
Federal Systems, Inc., San Diego, CA;
REACT Neuro, Cambridge, MA; Remote
Health LLC, Springfield, OH; Renovo
Concepts, Inc., San Antonio, TX;
Rensselaer Polytechnic Institute, Troy,
NY; Research Bridge Partners, Inc.,
Austin, TX; Resolys Bio, Inc., Delanson,
NY; RIVA Solutions, Inc., McLean, VA;
RTI International, Research Triangle
Park; SAIC, Reston, VA; Sandstone
Diagnostics, Inc., Pleasanton, CA;
SaNOtize Research & Development
Corp., Vancouver, CAN; Sense
Diagnostics Inc., Cincinnati, OH;
Sentien Biotechnologies, Lexington,
MA; ServiceNow, Inc., Vienna, VA;
Seventh Dimension, LLC, Mocksville,
NC; Shipcom Federal Solutions, LLC,
Belcamp, MD; Sibel Inc., Evanston, IL;
Sierra Nevada Corporation (SNC),
Sparks, NV; SightLife, Seattle, WA; Sim
Vivo LLC, Essex, NY; SimX, Inc.,
Mountain View, CA; Snoretox Pty Ltd,
Kew, Victoria, AUS; Softox Solutions
AS, Oslo, NOR; STEL Technologies,
LLC, Ann Arbor, MI; Stuart
Therapeutics Inc, Stuart, FL; Symbinas
Pharmaceuticals Inc., Jacksonville, FL;
Systems Engineering Solutions
Corporation, Greenbelt, MD; TechWerks
LLC; Arlington Heights, IL;
TeleCommunication Systems, Inc.,
Annapolis, MD; TensorX, Inc, Vienna,
VA; Texas A&M University, College
Station, TX; The Cleveland Clinic
Foundation, Cleveland, OH; The
Curators of the University of Missouri,
on behalf of Missouri University of
Science and Technology, Rolla, MO;
The Research and Recognition Project
Inc, Corning, NY; The Spaulding
Rehabilitation Corporation,
Charlestown, MA; The Spectrum Group,
LLC, Alexandria, VA; The University of
Alabama at Birmingham, Birmingham,
AL; The University of Tennessee Health
Science Center, Memphis, TN; The
University of Texas at Dallas,
Richardson, TX; Thornhill Reasearch
Inc., North York, Ontario, CAN;
Thornton Tomasetti, Inc., New York,
NY; Tiber Creek Partners, Tiber Creek
Partners, VA; Tissue Regeneration
Sciences, Inc, Park City, UT; TITUS
Sports Academy LLC, Tallahassee, FL;
Tomorrow Lab LLC, New York, NY;
Topadur Pharma AG, Schlieren, CHE;
Trifecta Solutions, Reston, VA; Triton
VerDate Sep<11>2014
16:16 Dec 08, 2020
Jkt 253001
Systems Inc, Chelmsford, MA; Trustees
of the University of Pennsylvania,
Philadelphia, PA; UNandUP, LLC, Saint
Louis, MO; Unissant, Inc., Herndon, VA;
Universal Consulting Services, Inc.,
Fairfax, VA; University of Arizona
Applied Research Corporation, Tucson,
AZ; University of Georgia Research
Foundation, Inc., Athens, GA;
University of Kansas Medical Center
Research Institute, Inc., Kansas City, KS;
University of North Carolina at Chapel
Hill, Chapel Hill, NC; University of
Ottawa, Ottawa, CAN; University of
South Carolina, Columbia, SC;
University of South Florida, Tampa, FL;
University of Southern California, Los
Angeles, CA; Vinformatix LLC, Baton
Rouge, LA; VIRGINIA HIGH
PERFORMANCE LLC, Virginia Beach,
VA; VirtuSense Technologies, Inc.,
Peoria, IL; Vista LifeSciences, Inc.,
Parker, CO; VXBIOSCIENCES, INC.,
Oakland, CA; Zane Networks, LLC,
Washington, DC; ZOLL Medical
Corporation, Chelmsford, MA; have
been added as parties to this venture.
Also, 21 MedTech, LLC, Burlington,
NC; 410 Medical, Inc., Elgin, NC; 911
Medical Devices, LLC, Houston, TX;
98point6 Inc., Seattle, WA; Adventist
Health System—Sunbelt, Inc. dba
Florida Hospital, Orlando, FL; Akron
Biotechnology, LLC, Boca Raton, FL;
American Type Culture Collection
(ATCC Federal Solutions), Manassas,
VA; Arrevus, Inc., Raleigh, NC;
Auckland UniServices Limited,
Auckland, NZL; Awarables Inc.,
Baltimore, MD; Axonova Medical, LLC,
Philadelphia, PA; Becton Dickinson &
Company, Franklin Lake, NJ; Biobeat
Technologies Ltd., Petach, Yikva, ISR;
BioSpyder Technologies, Inc., Carlsbad,
CA; Blood Systems, Inc. dba Blood
Systems Research Institute, Scottsdale,
AZ; bR3 UNIQ, Inc. dba QUADYSTER,
Bettendorf, IA; Bramante Bioscience,
Elmira Heights, NY; Brain Power, LLC,
Cambridge, MA; Caci, Inc.—Federal,
Chantilly, VA; Calimex USA
Corporation, San Francisco, CA; Carmell
Therapeutics Corporation, Pittsburgh,
PA; Case Western Reserve University,
Cleveland, OH; CFD Research
Corporation, Huntsville, AL; Combat
Medical Systems, Harrisburg, NC;
Cortical Metrics, LLC, Semora, NC;
Crius Technology Group, Austin, TX;
Detact Diagnostics BV, Hoge der,
Gronigen Netherlands; Droper Med
America, LLC, Elgin, SC; Engility
Corporation, Chantilly, VA; Existential
Technologies, Inc., Chula Vista, CA;
Family Health International DBA FHI
360, Durham, NC; FloTBI, Cleveland,
OH; FullSekurity Corporation, Irving,
TX; Full Spectrum Omega, Inc.,
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Huntington Beach, CA; Georgia Tech
Research Corporation, Atlanta, GA;
HeadsafelP Pty Ltd, Bronte, NSW, AUS;
Healios, Inc., Flemington, NJ;
Hemoclear B.V., Zwolle, Overijssel,
Netherlands; Howmedica Osteonics
Corp. dba Stryker Orthopaedics,
Mahwah, NJ; Human Biomed, Inc.,
Siuth Burlington, VT; HYPR Life
Sciences, Inc., Pilot Mountain, NC;
ImmunoVation, LLC, Pasadena, CA;
Integrum Scientific, LLC, Greensboro,
NC; Irving Burton Associates, Inc. (IBA),
Falls Church, VA; JumpStartCSR,
Seattle, WA; Knowledge Driven LLC,
Alexandria, VA; Kindred Biosciences,
Inc., Burlingame, CA; Lieber Institute,
Inc., Baltimore, MD; LongView
International Technology Solutions,
Inc., Herndon, VA; Magle Chemoswed
AB, Lund, SWE; Massachusetts Eye and
Ear Infirmary, Boston, MA; Melinta
Therapeutics, Inc., New Haven, CT;
MilanaPharm, LLC, Tallassee, AL;
Molecular Biologicals, Pasadena, TX;
MO–SCI Corporation, Rollo, MO; New
Horizons Diagnostics Corporation,
Baltimore, MD; New York University
School of Medicine, New York, NY;
Next Generation Stretcher Ltd, Raman
gan, ISR; NON–INVASIVE MEDICAL
SYSTEMS, LLC, Stamford, CT; NUES
LLC, Silver Spring, MD; Onera Health
Inc., Palo Alto, CA; PEER Technologies
PLLC, Fairfax, VA; Phagelux (Canada)
Inc., Montreal, CAN; Physcient, Inc.,
Durham, NC; Pluristem LTD, Haifa, ISR;
PolarityTE MD, Inc., Salt Lake City, UT;
Pop Test Oncology LLC aka Palisades
Therapeutics, Cliffside Park, NJ; Power
of Patients, LLC, Charleston, SC;
Praeses, LLC, Shreveport, LA; Prep
Tech, LLC, Westlake, LA; Pulmotect,
Inc., Houston, TX; Q2Pharma, Haifa,
ISR; Qrons, Inc., Miami, FL; Radical
Concepts LLC, Brooklyn, NY; RegenFix,
LLC, Toledo, OH; Remedor Biomed Ltd.,
Nazareth Illit, ISR; Roccor, LLC,
Longmont, CO; San Diego Blood Bank,
San Diego, CA; Scinus Cell Expansion
B.V., Bilthoven, Utrecht; Seran
Bioscience, Bend, OR; Sleep Care, Inc.,
Columbus, OH; SmartPoints
Technology, Inc., Stow, MA; Southern
Research Institute, Birmingham, AL;
SurgiBox Inc., Brookline, MA; Syracuse
University, Syracuse, NY; TBT Pharma,
LLC, Baltimore, MD; TearSolutions,
Inc., Charlottesville, VA; TerumoBCT,
Inc., Lakewood, CO; TheraNova, LLC,
San Francisco, CA; The University of
Arizona, Defense and Security Research
Institute (DSRI), Tucson, AZ; ThoraXS
Israel 17 Ltd, Tzur Hadassa, ISR;
Trailhead Biosystems Inc., Cleveland,
OH; Truecath Inc., Camarillo, CA;
Trustees of Boston University, Boston,
MA; University of Florida Division of
E:\FR\FM\09DEN1.SGM
09DEN1
Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices
Sponsored Programs, Gainesville, FL;
University of South Carolina, Columbia,
SC; University of Tartu, Tartu, EST;
Upside Biotechnologies Ltd., Auckland,
NZL; Virginia Polytechnic Institute and
State University, Blacksburg, VA; Wello,
Inc., Addison, TX; Williams-Jones
Consulting, Greenville, SC; Worcester
Polytechnic Institute, Worcester, MA; XTherma Inc., Richmond, CA; Yale
University, New Haven, CT have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MTEC
intends to file additional written
notifications disclosing all changes in
membership.
On May 9, 2014, MTEC filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 9, 2014 (79 FR 32999).
The last notification was filed with
the Department on October 17, 2019. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on November 12, 2019 (84 FR
61071).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2020–26978 Filed 12–8–20; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket No. OSHA–2020–0003]
Advisory Committee on Construction
Safety and Health (ACCSH)
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Request for nominations for
membership on ACCSH.
AGENCY:
The Secretary of Labor
requests nominations for membership
on ACCSH.
DATES: Submit (postmark, send,
transmit) nominations for ACCSH
membership by January 8, 2021.
ADDRESSES: You may submit
nominations and supporting materials
by one of the following methods:
Electronically: You may submit
nominations, including attachments,
electronically into Docket No. OSHA–
2020–0003 at https://
www.regulations.gov, which is the
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:16 Dec 08, 2020
Jkt 253001
Federal eRulemaking Portal. Follow the
online instructions for submissions.
Facsimile: If your nomination and
supporting materials, including
attachments, do not exceed 10 pages,
you may fax them to the OSHA Docket
Office at (202) 693–1648.
Regular mail, express mail, hand
delivery, or messenger (courier) service:
Submit materials to the OSHA Docket
Office, Docket No. OSHA–2020–0003,
Room N–3653, U.S. Department of
Labor, 200 Constitution Avenue NW,
Washington, DC 20210; telephone: (202)
693–2350. Please note: While OSHA’s
Docket Office is continuing to accept
and process requests, due to the
COVID–19 pandemic, the Docket Office
is closed to the public.
Instructions: All nominations and
supporting materials must include the
agency name and docket number for this
Federal Register document (Docket No.
OSHA–2020–0003). Because of securityrelated procedures, submitting
nominations by regular mail may result
in a significant delay in their receipt.
OSHA will post submissions in
response to this Federal Register
document, including personal
information provided, without change at
https://www.regulations.gov. Therefore,
OSHA cautions interested parties about
submitting personal information such as
Social Security Numbers and birthdates.
Access to docket: The https://
www.regulations.gov index lists all
submissions provided in response to
this Federal Register document;
however, some information (e.g.,
copyrighted material) is not publicly
available to read or download from that
web page. All submissions, including
materials not available online, are
available for inspection through the
OSHA Docket Office. For information
about accessing materials in Docket No.
OSHA–2020–0003, including materials
not available online, contact the OSHA
Docket Office.
FOR FURTHER INFORMATION CONTACT:
For press inquiries: Mr. Frank
Meilinger, Director, OSHA Office of
Communications; telephone: (202) 693–
1999; email: meilinger.francis2@dol.gov.
For general information about ACCSH
and ACCSH membership: Mr. Damon
Bonneau, OSHA, Directorate of
Construction; telephone: (202) 693–
2020; email: bonneau.damon@dol.gov.
Copies of this Federal Register
document: Electronic copies of this
Federal Register document are available
at https://www.regulations.gov. This
document, as well as news releases and
other relevant information are also
available on the OSHA web page at
https://www.osha.gov.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
79221
The
Secretary of Labor invites interested
persons to submit nominations for
membership on ACCSH.
SUPPLEMENTARY INFORMATION:
A. Background
ACCSH advises the Secretary of Labor
and the Assistant Secretary of Labor for
Occupational Safety and Health
(Assistant Secretary) in the formulation
of standards affecting the construction
industry, and on policy matters arising
in the administration of the safety and
health provisions under the Contract
Work Hours and Safety Standards Act
(Construction Safety Act (CSA)) (40
U.S.C. 3701 et seq.) and the
Occupational Safety and Health Act of
1970 (OSH Act) (29 U.S.C. 651 et seq.)
(see also 29 CFR 1911.10 and 1912.3). In
addition, the OSH Act and CSA require
the Assistant Secretary to consult with
ACCSH before the agency proposes any
occupational safety and health standard
affecting construction activities (29 CFR
1911.10; 40 U.S.C. 3704).
ACCSH operates in accordance with
the Federal Advisory Committee Act
(FACA), as amended (5 U.S.C. App. 2),
and the implementing regulations (41
CFR 102–3 et seq.); and Department of
Labor Manual Series Chapter 1–900 (8/
31/2020). ACCSH generally meets two
to four times a year.
B. ACCSH Membership
ACCSH consists of 15 members whom
the Secretary appoints. ACCSH
members generally serve staggered twoyear terms, unless they resign, cease to
be qualified, become unable to serve, or
the Secretary removes them (29 CFR
1912.3(e)). The Secretary may appoint
ACCSH members to successive terms.
No member of ACCSH, other than
members who represent employers or
employees, shall have an economic
interest in any proposed rule that affects
the construction industry (29 CFR
1912.6).
The categories of ACCSH
membership, and the number of new
members to be appointed to replace
members whose terms will expire, are:
• Five members who are qualified by
experience and affiliation to present the
viewpoint of employers in the
construction industry—five employer
representatives will be appointed;
• Five members who are similarly
qualified to present the viewpoint of
employees in the construction
industry—five employee representatives
will be appointed;
• Two representatives of State safety
and health agencies—two
representatives from a State safety and
health agency will be appointed;
E:\FR\FM\09DEN1.SGM
09DEN1
Agencies
[Federal Register Volume 85, Number 237 (Wednesday, December 9, 2020)]
[Notices]
[Pages 79219-79221]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26978]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to The National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on November 18, 2020, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology
Enterprise Consortium (``MTEC'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically, Abram Scientific, Inc., Menlo Park, CA;
Accenture Federal Services, Arlington, VA; Ace Laboratories Inc.,
Yarrow Point, WA; Aceso Plasma, Virginia Beach, VA; ACF Technologies,
Inc, Asheville, NC; Action Medical Technologies LLC, Conshohocken, PA;
Acuity Systems, LLC, Herndon, VA; Aerpio Pharmaceuticals, Cincinnati,
OH; AirStrip Technologies, San Antonio, TX; Airway Medical Innovations
Pty Ltd, Brisbane Queensland, AUS; Aktivax, Inc., Broomfield, CO;
Allvivo Vascular, Inc., Lake Forest, CA; Altimmune, Inc., Gaithersburg,
MD; Amydis, Inc., San Diego, CA; Aptahem AB, Malmo, SWE; Aptive
Resources, LLC, Alexandria, VA; ARD Global LLC, McLean, VA; Articulate
Labs, Dallas, TX; Ashvattha Therapeutics, Inc, Redwood City, CA;
Astrocyte Pharmaceuticals Inc., Cambridge, MA; Asymmetric Technologies,
LLC, Columbus, OH; Athena GTX, Johnston, IA; Atomo, Inc, West Lake
Hills, TX; Augusta University Resarch lnstitute, Inc., Augusta, GA;
Augustine Consulting, Inc. (ACI), Monterrey, CA; Auxocell Laboratories,
Inc, Cambridge, MA; Avera Health, Sioux Falls, SD; Bambu Vault, LLC,
Lowell, MA; Berry Consultants, LLC, Austin, TX; Beyond Barriers
Therapeutics, Inc., Glencoe, IL; Bioflight, LLC, Akron, OH;
BioGenerator, Saint Louis, MO; Biotags LLC, Key Biscayne, FL; Blue
Cirrus Consulting LLC, Greenville, SC; Board of Trustees of the
University of Illinois, Champaign, IL; Brainbox Solutions Inc.,
Richmond, VA; CAPRICOR THERAPEUTICS, INC., Beverly, CA; Carahsoft
Technology Corporation, Reston, VA; Centivax, Inc., South San
Francisco; Ceras Health Inc., New York, NY; Channel Clinical Solutions,
LLC, Raleigh, NC; Chenega Reliable Services, LLC, San Antonio, TX;
Cherish Health, Inc., Cambridge, MA; Clarkson University, Potsdam, NY;
Coalition for National Trauma Research, San Antonio, TX; Computer
Technology Associates, Inc., Ridgecrest, CA; Conflict Kinetics
Corporation, Sterling, VA; Core Mobile Networks Inc.; DBA Core Mobile
Inc., Campbell, CA; Crimson Government LLC, Carlisle, OH; Curza Global,
LLC, Salt Lake City, UT; Data Intelligence Technologies, Inc.,
Arlington, VA; DEFTEC Corporation, Huntsville, AL; Digital For Mental
Health (MYNDBLUE), Paris, FRA; Diomics Corporation, Murrietta, CA;
DocBox Inc., Waltham, MA; EchoNous Inc., Redmond, WA; ECI Defense
Group, Lyles, TN; Empatica, Inc., Boston, MA; Endomedix Inc.,
Montclair, NJ; Etiometry Inc., Boston, MA; Eumentis Therapeutics Inc,
Newton, MA; Exciton Technologies Inc., Edmonton, Alberta, CAN;
Expesicor Inc., Missoula, MT; FesariusTherapeutics Inc., Brooklyn, NY;
FHI Clinical Inc., Durham, NC, Fitbit, Inc., San Franciso, CA;
Flashback Technologies, Inc., Louisville, CO; FloTBI Inc., Cleveland,
OH; FUJIFILM Pharmaceuticals USA, Inc., Valhalla, NY; GelMEDIX Inc.,
Newton, MA; GeneCapture, Inc., Huntsville, AL; General Biologics Inc.,
Cambridge, MA; Get Help Now LLC, Fort Myers, FL; GreyScan Inc.,
Melbourne, FL; Heat Biologics, Morrisville, NC; Hememics
Biotechnologies Inc, Gaithersburg, MD; Hough Ear Institute, Oklahoma
City, OK; Humanetics Corporation, Edina, MN; Hybrid Plastics Inc.,
Hattiesburg, MS; Iacta Pharmaceuticals Inc, Irvine, CA; Ichor Sciences,
LLC, Nashville, TN; ImmunoVation, LLC, Pasadena, CA; INCELL Corporation
LLC, San Antonio, TX; Infectious Disease Research Institute, Seattle,
WA; Inflammatory Response Research Inc., Santa Barbara, CA; Informa
Business Intelligence Inc., New York, NY; Inhalon Biopharma, Inc.,
Durham, NC; Innovenn, Inc., Madison, WI; Innsightful, Inc., Sunnyvale,
CA; Integrated Computer Solutions, Inc., Waltham, MA; InTouch
Technologies, D/B/A Inc. InTouch Health, Goleta, CA; J.R. Reingold &
Associates, Inc, Alexandria, VA; JTEK Data Solutions, LLC, Bethesda,
MD; KMASS SOLUTIONS, El Paso, TX; Knowmadics, Inc., Herndon, VA; Level
Ex, Inc., Chicago, IL; LifeQ, Inc, Alphaertta, GA; LMI Consulting, LLC,
Tysons, VA; LOGGEREX INC., Deland, FL; Lumen Bioscience, Inc., Seattle,
WA; Luna Innovations Incorporated, Roanoke, VA; MadApparel Ind. DBA
Athos, Redwood City, CA; ManTech Advanced Systems International, Inc.,
Herndon, VA; Mantel Technologies Inc., Fort Collins, CO; Masimo
Corporation, Irvine, CA; Materials Modification Inc., Fairfax, VA;
Medcura, Inc., Riverdale, MD; Media Riders Inc., Pearland, TX; Medical
Center of the Americas Foundation, El Paso, TX; Medicortex Finland Oy,
Turku, FIN; Medtrade Products Limited, Crew, Cheshire, GBR; MEMBIO
INC., Kitchener, CAN; Mespere LifeSciences Inc., Waterloo, Ontario,
CAN; MicroHealth, LLC, Vienna, VA; Microsoft, Redmon, VA; Millennium
Enterprise Corporation, Fairfax, VA; Mineurva LLC, Albuquerque, NM;
Moberg Analytics Inc., Ambler, PA; Moleculin Biotech, Inc., Houston,
TX; Nanowear Inc., New York, NY; Neuronasal Inc, Wexford, PA;
Neuronoff, Inc., Valencia, CA; New Horizons Diagnostics Corporation,
Baltimore, MD; New Jersey Institute of Technology, Newark, NJ; NoMo
Diagnostics, Chicago, IL; Non-Invasive Medical Systems LLC, Stamford,
CT; North Carolina State University, Raleigh, NC; Northwestern
University, Evanson, IL; Nostromo, LLC, Kennebunk, ME; Nuada
Orthopedics, Inc., Sherborn, MA; Nyrada Inc., Gordon, AUS; Obatala
Sciences, Inc., New Orleans, LA; Oculogica, Inc., New York, NY; Odin
Technologies, Chicago, IL; OLGS Inc., Imperial, PA; Oregon Health &
Science University, Portland, OR; Otolith Labs, Washington, DC;
[[Page 79220]]
Panakeia LLC, Newport News, VA; Parnell Pharmaceuticals Inc., San
Rafael, CA; Patchd, Inc., San Francisco, CA; Perspecta Enterprise
Solutions LLC, Herndon, VA; Pinteon Therapeutics, Newton Center, MA;
Posit Science Corporation, San Francisco, CA; PPD Development LP,
Wilmington, NC; Predictions Systems Inc., Spring Lake, NJ; Promaxo,
Oakland, CA; QUASAR Federal Systems, Inc., San Diego, CA; REACT Neuro,
Cambridge, MA; Remote Health LLC, Springfield, OH; Renovo Concepts,
Inc., San Antonio, TX; Rensselaer Polytechnic Institute, Troy, NY;
Research Bridge Partners, Inc., Austin, TX; Resolys Bio, Inc.,
Delanson, NY; RIVA Solutions, Inc., McLean, VA; RTI International,
Research Triangle Park; SAIC, Reston, VA; Sandstone Diagnostics, Inc.,
Pleasanton, CA; SaNOtize Research & Development Corp., Vancouver, CAN;
Sense Diagnostics Inc., Cincinnati, OH; Sentien Biotechnologies,
Lexington, MA; ServiceNow, Inc., Vienna, VA; Seventh Dimension, LLC,
Mocksville, NC; Shipcom Federal Solutions, LLC, Belcamp, MD; Sibel
Inc., Evanston, IL; Sierra Nevada Corporation (SNC), Sparks, NV;
SightLife, Seattle, WA; Sim Vivo LLC, Essex, NY; SimX, Inc., Mountain
View, CA; Snoretox Pty Ltd, Kew, Victoria, AUS; Softox Solutions AS,
Oslo, NOR; STEL Technologies, LLC, Ann Arbor, MI; Stuart Therapeutics
Inc, Stuart, FL; Symbinas Pharmaceuticals Inc., Jacksonville, FL;
Systems Engineering Solutions Corporation, Greenbelt, MD; TechWerks
LLC; Arlington Heights, IL; TeleCommunication Systems, Inc., Annapolis,
MD; TensorX, Inc, Vienna, VA; Texas A&M University, College Station,
TX; The Cleveland Clinic Foundation, Cleveland, OH; The Curators of the
University of Missouri, on behalf of Missouri University of Science and
Technology, Rolla, MO; The Research and Recognition Project Inc,
Corning, NY; The Spaulding Rehabilitation Corporation, Charlestown, MA;
The Spectrum Group, LLC, Alexandria, VA; The University of Alabama at
Birmingham, Birmingham, AL; The University of Tennessee Health Science
Center, Memphis, TN; The University of Texas at Dallas, Richardson, TX;
Thornhill Reasearch Inc., North York, Ontario, CAN; Thornton Tomasetti,
Inc., New York, NY; Tiber Creek Partners, Tiber Creek Partners, VA;
Tissue Regeneration Sciences, Inc, Park City, UT; TITUS Sports Academy
LLC, Tallahassee, FL; Tomorrow Lab LLC, New York, NY; Topadur Pharma
AG, Schlieren, CHE; Trifecta Solutions, Reston, VA; Triton Systems Inc,
Chelmsford, MA; Trustees of the University of Pennsylvania,
Philadelphia, PA; UNandUP, LLC, Saint Louis, MO; Unissant, Inc.,
Herndon, VA; Universal Consulting Services, Inc., Fairfax, VA;
University of Arizona Applied Research Corporation, Tucson, AZ;
University of Georgia Research Foundation, Inc., Athens, GA; University
of Kansas Medical Center Research Institute, Inc., Kansas City, KS;
University of North Carolina at Chapel Hill, Chapel Hill, NC;
University of Ottawa, Ottawa, CAN; University of South Carolina,
Columbia, SC; University of South Florida, Tampa, FL; University of
Southern California, Los Angeles, CA; Vinformatix LLC, Baton Rouge, LA;
VIRGINIA HIGH PERFORMANCE LLC, Virginia Beach, VA; VirtuSense
Technologies, Inc., Peoria, IL; Vista LifeSciences, Inc., Parker, CO;
VXBIOSCIENCES, INC., Oakland, CA; Zane Networks, LLC, Washington, DC;
ZOLL Medical Corporation, Chelmsford, MA; have been added as parties to
this venture.
Also, 21 MedTech, LLC, Burlington, NC; 410 Medical, Inc., Elgin,
NC; 911 Medical Devices, LLC, Houston, TX; 98point6 Inc., Seattle, WA;
Adventist Health System--Sunbelt, Inc. dba Florida Hospital, Orlando,
FL; Akron Biotechnology, LLC, Boca Raton, FL; American Type Culture
Collection (ATCC Federal Solutions), Manassas, VA; Arrevus, Inc.,
Raleigh, NC; Auckland UniServices Limited, Auckland, NZL; Awarables
Inc., Baltimore, MD; Axonova Medical, LLC, Philadelphia, PA; Becton
Dickinson & Company, Franklin Lake, NJ; Biobeat Technologies Ltd.,
Petach, Yikva, ISR; BioSpyder Technologies, Inc., Carlsbad, CA; Blood
Systems, Inc. dba Blood Systems Research Institute, Scottsdale, AZ; bR3
UNIQ, Inc. dba QUADYSTER, Bettendorf, IA; Bramante Bioscience, Elmira
Heights, NY; Brain Power, LLC, Cambridge, MA; Caci, Inc.--Federal,
Chantilly, VA; Calimex USA Corporation, San Francisco, CA; Carmell
Therapeutics Corporation, Pittsburgh, PA; Case Western Reserve
University, Cleveland, OH; CFD Research Corporation, Huntsville, AL;
Combat Medical Systems, Harrisburg, NC; Cortical Metrics, LLC, Semora,
NC; Crius Technology Group, Austin, TX; Detact Diagnostics BV, Hoge
der, Gronigen Netherlands; Droper Med America, LLC, Elgin, SC; Engility
Corporation, Chantilly, VA; Existential Technologies, Inc., Chula
Vista, CA; Family Health International DBA FHI 360, Durham, NC; FloTBI,
Cleveland, OH; FullSekurity Corporation, Irving, TX; Full Spectrum
Omega, Inc., Huntington Beach, CA; Georgia Tech Research Corporation,
Atlanta, GA; HeadsafelP Pty Ltd, Bronte, NSW, AUS; Healios, Inc.,
Flemington, NJ; Hemoclear B.V., Zwolle, Overijssel, Netherlands;
Howmedica Osteonics Corp. dba Stryker Orthopaedics, Mahwah, NJ; Human
Biomed, Inc., Siuth Burlington, VT; HYPR Life Sciences, Inc., Pilot
Mountain, NC; ImmunoVation, LLC, Pasadena, CA; Integrum Scientific,
LLC, Greensboro, NC; Irving Burton Associates, Inc. (IBA), Falls
Church, VA; JumpStartCSR, Seattle, WA; Knowledge Driven LLC,
Alexandria, VA; Kindred Biosciences, Inc., Burlingame, CA; Lieber
Institute, Inc., Baltimore, MD; LongView International Technology
Solutions, Inc., Herndon, VA; Magle Chemoswed AB, Lund, SWE;
Massachusetts Eye and Ear Infirmary, Boston, MA; Melinta Therapeutics,
Inc., New Haven, CT; MilanaPharm, LLC, Tallassee, AL; Molecular
Biologicals, Pasadena, TX; MO-SCI Corporation, Rollo, MO; New Horizons
Diagnostics Corporation, Baltimore, MD; New York University School of
Medicine, New York, NY; Next Generation Stretcher Ltd, Raman gan, ISR;
NON-INVASIVE MEDICAL SYSTEMS, LLC, Stamford, CT; NUES LLC, Silver
Spring, MD; Onera Health Inc., Palo Alto, CA; PEER Technologies PLLC,
Fairfax, VA; Phagelux (Canada) Inc., Montreal, CAN; Physcient, Inc.,
Durham, NC; Pluristem LTD, Haifa, ISR; PolarityTE MD, Inc., Salt Lake
City, UT; Pop Test Oncology LLC aka Palisades Therapeutics, Cliffside
Park, NJ; Power of Patients, LLC, Charleston, SC; Praeses, LLC,
Shreveport, LA; Prep Tech, LLC, Westlake, LA; Pulmotect, Inc., Houston,
TX; Q2Pharma, Haifa, ISR; Qrons, Inc., Miami, FL; Radical Concepts LLC,
Brooklyn, NY; RegenFix, LLC, Toledo, OH; Remedor Biomed Ltd., Nazareth
Illit, ISR; Roccor, LLC, Longmont, CO; San Diego Blood Bank, San Diego,
CA; Scinus Cell Expansion B.V., Bilthoven, Utrecht; Seran Bioscience,
Bend, OR; Sleep Care, Inc., Columbus, OH; SmartPoints Technology, Inc.,
Stow, MA; Southern Research Institute, Birmingham, AL; SurgiBox Inc.,
Brookline, MA; Syracuse University, Syracuse, NY; TBT Pharma, LLC,
Baltimore, MD; TearSolutions, Inc., Charlottesville, VA; TerumoBCT,
Inc., Lakewood, CO; TheraNova, LLC, San Francisco, CA; The University
of Arizona, Defense and Security Research Institute (DSRI), Tucson, AZ;
ThoraXS Israel 17 Ltd, Tzur Hadassa, ISR; Trailhead Biosystems Inc.,
Cleveland, OH; Truecath Inc., Camarillo, CA; Trustees of Boston
University, Boston, MA; University of Florida Division of
[[Page 79221]]
Sponsored Programs, Gainesville, FL; University of South Carolina,
Columbia, SC; University of Tartu, Tartu, EST; Upside Biotechnologies
Ltd., Auckland, NZL; Virginia Polytechnic Institute and State
University, Blacksburg, VA; Wello, Inc., Addison, TX; Williams-Jones
Consulting, Greenville, SC; Worcester Polytechnic Institute, Worcester,
MA; X-Therma Inc., Richmond, CA; Yale University, New Haven, CT have
withdrawn as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
Section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to Section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on October 17,
2019. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on November 12, 2019 (84 FR 61071).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2020-26978 Filed 12-8-20; 8:45 am]
BILLING CODE 4410-11-P